EyeGate licenses orphan eye disease patents to Avedro

Mass High Tech: The Journal of New England Technology

EyeGate Pharmaceuticals Inc. is licensing its patents relating to a treatment for an orphan eye disease called keratoconus to its Waltham neighbor Avedro Inc. for an undisclosed sum.